Kertscher H P, Schmidt B, Ostermann G
Sektion Biowissenschaften, Universität Leipzig.
Pharmazie. 1992 Mar;47(3):172-4.
A series of 11 PAF-analogues, structurally modified in position 1 (alkylcarbamoyloxy), position 2 (n-propyl), and position 3 (polar head group) were synthesized, and the inhibitory potencies on human blood platelets in vitro was evaluated. Investigations of structure-activity relationships revealed, that the PAF antagonist activity is strongly influenced by the chain length of the alkylcarbamoyl residue and the structure of the polar head group. Derivatives with pentadecyl and octadecylcarbamoyl structure emerged effective inhibitors. The best activity was observed by dimethylaminopyridinium, analogues with a P-N distance of 3 or 4 methylene groups and pentadecyl or octadecylcarbamoyl structure (IC50 = 1.0-1.6 mumol/l).
合成了一系列11种PAF类似物,它们在1位(烷基氨基甲酰氧基)、2位(正丙基)和3位(极性头部基团)进行了结构修饰,并评估了其对人血小板的体外抑制效力。构效关系研究表明,PAF拮抗剂活性受烷基氨基甲酰残基的链长和极性头部基团结构的强烈影响。具有十五烷基和十八烷基氨基甲酰结构的衍生物是有效的抑制剂。二甲基氨基吡啶鎓、P-N距离为3或4个亚甲基且具有十五烷基或十八烷基氨基甲酰结构的类似物表现出最佳活性(IC50 = 1.0 - 1.6 μmol/l)。